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PLSAbstract b-Carboline moieties are important structural subunits which occur as components of
many biologically interesting molecules for antitumor activity. Quantitative structure–activity rela-
tionship (QSAR) studies have been performed on b-carboline derivatives to explore the structural
necessities for antitumor activity. 3D QSAR studies were done using V-Life Sciences MDS 3.0 drug
designing module to explain the structural requirements for the anti-tumor activity. The 3D-QSAR
was performed using the Step Wise K Nearest Neighbour Molecular Field Analysis [(SW) kNN
MFA] technique with the partial least-square (PLS) method on a database. Obtained best 3D-
QSAR model having high predictive ability with q2 = 0.743, r2 = 0.721, pred_r2 = 0.708 and stan-
dard error = 0.346, explaining the majority of the variance in the data with partial least square
(PLS) components. The results of the present study may be useful on the designing of more potent
compounds as antitumor drugs.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The b-carboline alkaloids are a class of synthetic and naturally
occurring compounds that possess a large range of important
pharmacological properties such as sedative, anxiolytic, hyp-
notic, anticonvulsant, antitumor, antiviral, antiparasitic, anti-
microbial and anti-HIV activities (Caiping et al., 2010;Ishida et al., 2001). Other reports have revealed that b-carbo-
line alkaloids can exert antitumor activities through multiple
mechanisms, such as intercalating into DNA (Xiao et al.,
2001), inhibiting topoisomerases I and II (Funayama et al.,
1996), CDKs (cyclindependent kinases; Li et al., 2007), IjB ki-
nases (Castro et al., 2003) and mitotic kinesin Eg5 (Sunder-
Plassmann et al., 2005).
The b-carbolines bearing a ﬂexible alkylamine side chain in
position-3 showed potent DNA intercalating abilities resulting
in noteworthy antitumor potencies (Xiao et al., 2001). The
complex polycyclic ring system in position-1 of b-carboline nu-
cleus of manzamine A can be replaced with simpler amino sub-
stituents to offer active compounds (Boursereau and Coldham,
2004). Structure–activity relationships (SARs) for in vitro and
in vivo antitumor activities showed that (a) the antitumor
QSAR analysis for some b-carboline derivatives as anti-tumor 537potential of b-carbolines correlated to both the planarity of the
molecule and the presence of substituents in position-1, 3 and 9
of b-carboline nucleus; (b) the introduction of appropriate sub-
stituents into these positions of b-carboline scaffold played a
crucial role in the modulation of their antitumor efﬁcacies
(Chunming et al., 2010). Most of these b-carboline derivatives
are endowed with antitumor, and DNA intercalating proper-Table 1 Structure of training and test sets of b-carboline derivative
N
R4
R5.
Compound No. Substituents
R1 R2 R3
1 3,4,5-trimethoxyphenyl – CO2H
2 H – CONH(CH2)2N
3 H – CONH(CH2)6N
4 CH3 – CONH(CH2)2O
5 CH3 – CONH(CH2)2N
6* CH3 – CONH(CH2)2N
7 H – CONH(CH2)2N
8 H – CONH(CH2)6N
9 CH3 – CH2OH
10 CH3 – CHO
11 CH3 CH2C6H5 H
12 CH3 (CH2)3C6H5 H
13 CH3 CH2C6H5 CO2C2H5
14* CH3 CH2C6H5 H
15 H n-C4H9 H
16 H CH2C6H5 H
17* H (CH2)3C6H5 H
18 CH3 – H
19 CH3 – H
20 CH3 – H
21* CH3 – H
22 CH3 – H
23 CH3 – H
24 CH3 – H
25 CH3 – H
26 CH3 – H
27 CH3 – H
28 CH3 – H
29 CH3 – H
30* CH3 – H
31 CH3 – H
32 CH3 – H
33 CH3 – H
34 CH3 CH2C6H5 H
35 CH3 CH2C6H5 H
36 CH3 CH2C6H5 H
37 CH3 CH2C6H5 H
38* CH3 CH2C6H5 H
* Asterisk showing test compounds.ties and their high DNA binding afﬁnity is thought to be par-
tially responsible for their pharmacological action (Ikeda et al.,
2011).
Quantitative structure–activity relationships (QSARs) are
an effort to correlate the structural or property descriptors
of compounds quantitatively with biological activities. The
most important aspect of QSAR is to establish a correlations and their experimental antitumor activity.
N
R3
R1
R2
Br-
Actual activity Hela [IC50 (lM)]
R4 R5
H n-C4H9 166
H2 H n-C4H9 26.9
H2 H n-C4H9 53
H H n-C4H9 80.4
H2 H n-C4H9 13.3
H2 H CH2C6H5 11
H2 H CH2C6H5 42.8
H2 H CH2C6H5 24.2
H n-C4H9 100
H n-C4H9 169
H H 69.2
H H 49.8
H H 101
OCH3 H 77.6
H H 130
H H 85.4
H H 44.3
OH C2H5 70.3
OH n-C4H9 89.8
OH i-C4H9 68.3
OH (CH2)3C6H5 45.3
OC2H5 C2H5 30.7
OCH2C6F5 C2H5 258
OC2H5 n-C4H9 32.1
OCH(CH3)2 n-C4H9 21.2
OC4H9 n-C4H9 17.4
OC10H21 n-C4H9 106
OC4H9 i-C4H9 20.8
OCH2C6H5 i-C4H9 50.5
OCH(CH3)2 (CH2)3C6H5 48.6
OC8H17 (CH2)3C6H5 69.6
OCH2C6H5 (CH2)3C6H5 72.6
OCH2C6F5 (CH2)3C6H5 73.5
OC2H5 C2H5 2.2
OCH2C6F5 C2H5 0.93
OC4H9 i-C4H9 2.6
OCH2C6H5 i-C4H9 12.4
OC8H17 (CH2)3C6H5 2.2
Table 2 Uni-Column statistics for 3D QSAR model.
Data set Average Max. Min. Std. dev. Sum
Training set 4.398 6.032 3.588 0.552 140.727
Test set 4.623 5.658 4.110 0.582 27.738
Max. = maximum, Min. = minimum, Std. dev. = Standard
deviation.
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Figure 1 Comparison of actual activity versus predicted activity for regression analysis of 3D QSAR model.
538 R.K. Chourasiya et al.between various molecular properties of a set of molecules
with their experimentally known biological activity (Sahu
et al., 2012). 3D QSAR is calculated initial from a geometrical
or 3D representation of a molecule. These descriptors include
molecular volume, molecular surface and other geometrical
properties. There are different types of 3D descriptors for
example electronic, steric, hydrogen bond donor, hydrogenFigure 2 Stereoview of the molecular rectangular ﬁeld grid around t
using SW kNN MFA method (Alignment of the molecules).bond acceptor and hydrophobic, etc. (Ravichandran et al.,
2007).
In the search of newer b-carboline entities with improved
antitumor activity present study deals with 3D QSAR ap-
proaches using V-Life Sciences Version 3.0 molecular design
software to ﬁnd out structure features required for biological
activity.
2. Materials and methods
2.1. Data set
A dataset of thirty-eight b-carboline derivatives has been taken
for the present QSAR studies (Cao et al., 2010) (Table 1). The
activity data were given as IC50 values, where IC50 refers to the
experimentally determined micromolar concentration of the b-
carboline required to inhibit the cervical tumor cells by 50%.he superposed molecular units of b-carboline series of compounds
Table 3 Statistical results of 3D QSAR model generated by
SW kNN MFA method for b-carboline derivatives.
Sr. No. Statistical parameter 3D QSAR Results
1 r2 0.721
2 r2SE 0.306
3 q2 0.743
4 q2SE 0.346
5 Pred_r2 0.708
6 Pred_r2SE 0.395
7 F-test 24.185
8 N 32
9 Contributing descriptors S_797 (17%)
S_1654 (25%)
E_1505 (41%)
S_927 (17%)
Constant-4.113
Table 4 Predicted activity along with residual obtained from
SW kNN MFA method of 3D-QSAR model.
Compound No. Actual activity (pIC50) 3D QSAR model (pIC50)
Predicted activity Residual
1 3.78 4.106 0.326
2 4.57 4.065 0.505
3 4.276 4.048 0.228
4 4.095 4.003 0.092
5 4.876 4.274 0.602
6* 4.959 5.546 0.587
7 4.368 4.472 0.104
8 4.616 4.442 0.174
9 4 4.041 0.041
10 3.772 4.079 0.307
11 4.16 4.699 0.539
12 4.303 4.247 0.056
13 3.996 4.239 0.243
14* 4.11 4.308 0.198
15 3.886 4.058 0.172
16 4.068 4.078 0.01
17* 4.353 4.066 0.287
18 4.153 4.094 0.059
19 4.047 4.095 0.048
20 4.165 4.099 0.066
21* 4.344 4.069 0.275
22 4.513 4.348 0.165
23 3.589 4.299 0.71
24 4.493 4.569 0.076
25 4.674 4.577 0.097
26 4.759 4.569 0.19
27 3.975 4.099 0.124
28 4.682 4.611 0.071
29 4.297 4.115 0.182
30* 4.313 4.58 0.267
31 4.157 4.409 0.252
32 4.139 4.407 0.268
33 4.134 4.075 0.059
34 5.657 5.205 0.452
35 6.031 6.059 0.028
36 5.585 5.49 0.095
37 4.906 4.976 0.07
38* 5.657 6.005 0.348
# showing Residual, Residual = Actual  predicted activity.
* Asterisk showing test compounds.
QSAR analysis for some b-carboline derivatives as anti-tumor 539The biological activity values [IC50 (lM)] reported in the liter-
ature were converted into their molar units and then further
into negative logarithmic scale (pIC50) and subsequently used
as the dependent variable for the QSAR analysis. All thirty-
eight compounds were drawn on the workspace of V-Life
Science molecular modeling software version 3.0. Energy min-
imization is the essential step and was carried out using the
standard Merck Molecular Force Field (MMFF) method with
distance dependent-dielectric function with energy gradient of
0.001 kcal/mol and iteration limit of 10000 implemented in V-
Life molecular milder database (Jain et al., 2008; Vaidya et al.,
2011; Prasad et al., 2009). However, in 3D QSAR molecular
alignment was carried out by template based alignment using
compound having the highest pIC50 (compound No. 35) served
as template, followed by generation of common rectangular
grid of 2 around the aligned molecules.
2.2. Descriptors
For 3D QSAR steric and electrostatic ﬁelds were generated at
the lattice points of grid using methyl probe of charge + 1.
The ﬁelds were generated by kNN method with default energy
of 30 kcal/mol and 10 kcal/mol, respectively. Partial atomic
charges were calculated using the Gasteiger-Marsii method
(Shen et al., 2003).
Negative range in electrostatic ﬁeld descriptors (blue points
in the dialog box) indicates that negative electronic potential is
favorable for activity and more electronegative substituents
group is favored in that position, positive electronic potential
range indicates the vice versa of negative potential. Positive va-
lue of steric descriptors (green points in the dialog box) reveals
that positive steric potential is constructive for an increase in
activity and more bulky group is preferred in that region, neg-
ative steric potential range indicates the vice versa of negative
potential.
2.3. Regression analysis
For 3D QSAR, regression analysis was performed via partial
least-square (PLS) method and cross-validation was done
using leave-one-out (LOO) method with 0.5 kcal/mol column
ﬁlter. Models were generated with [(SW) kNN MFA]
approach via stepwise forward–backward method set as vari-
ance cut-off 2.0 kcal/mol using auto scaling (Wold, 1995)
(Fig. 1).
The ﬁnal models were developed on the basis of statisti-
cal parameters including optimum number of components
(N), correlation coefﬁcient (r), square of correlation coefﬁ-
cient (r2), cross-validated correlation coefﬁcient (q2), r2 for
external test set (pred_r2), F-test (Fischer’s value) for statis-
tical signiﬁcance and standard error of estimation (r2 se)
(Table 2).
From the statistical viewpoint, the ratio of the number of
samples (N) to the number of variables used (M) should be
N/MP 5.
2.4. Cross validation
The cross-validated correlation coefﬁcient (q2) of the generated
model was calculated using the equation:
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Figure 3 Contributions of descriptors for biological activity
developed using SW-kNN-MFA equation for 3D QSAR.
540 R.K. Chourasiya et al.q2 ¼ 1
Pðyi  y^iÞ2
Pðyi  ymeanÞ2
The predicted ability (pred_r2) of statistical models indicates
the predictive power of the current model for the external test
and calculated using the equation:
Pred r2 ¼ 1
Pðyi  y^iÞ2
Pðyi  ymeanÞ2
Both summations are over all molecules in the test set.
Where yi and y^i are the actual and predicted activities of the
ith molecule in the test set, respectively, and ymean is the aver-
age activity of all molecules in the training set. Both summa-
tions are over all molecules in the training set (Samee et al.,
2008; www.Vlifesciences.com).
3. Results and discussion
In the present study the authors tried to develop the best 3D
QSAR models using V-Life MDS to explain the correlation be-Figure 4 Common template used for alignment of b-carbotween the parameters and the antitumor activity of b-carboline
derivatives.
3.1. 3D QSAR results
To derive 3D QSAR models via V-Life MDS, the kNN
descriptors (steric and electrostatic) were used as independent
variables and antitumor activity as a dependent variable. After
alignment steric and electrostatic ﬁelds were generated to de-
rive 3D QSAR models (Fig. 2). Various models have been
developed by changing training and test set data. For the best
selected model compound Nos. 06, 14, 17, 21, 30 and 38 serve
as test set data, while remaining are training set compounds.
The results of uni-column statistics are summarized in Table 2,
which shows that the test is interpolative. Finally, the statisti-
cal results are listed in Table 3 and shows that the model hav-
ing good internal and external predictive ability with minimum
residual activity was selected (Table 4).
For the selected kNN MFA model, the cross-validated r2
(q2) value of the training set was 0.743 with principal compo-
nent. The non-cross-validated r2 value was 0.721 with standard
error 0.346 and covariance ratio (F) of 24.185 (signiﬁcant at
99.99% level). The predictive ability of model was also con-
ﬁrmed by external pred_r2 having the value 0.708.
In kNNMFAmodel, the steric parameter contributes 59%,
while electrostatic parameter accounts for 41%. Contributions
of steric and electrostatic parameters are shown in Fig. 3. The
contribution plot of steric and electrostatic ﬁeld interactions
indicates relative regions of the local ﬁelds (steric and electro-
static) around the aligned molecules, leading to activity distinc-
tion in the model. The green-colored balls specify the positions
of the steric descriptors and the descriptor with positive or neg-
ative coefﬁcients indicates a region where bulky substituent is
favored or unfavored, respectively. Electrostatic ﬁeld descrip-
tors (blue-colored balls) with positive coefﬁcients represent re-
gions where less electronegative group is favorable, whereasline derivatives in the context of most potent compound.
Figure 5 Common template used for alignment of b-carboline derivatives in the context of least active compound.
QSAR analysis for some b-carboline derivatives as anti-tumor 541negative coefﬁcient shows that more electronegative group is
favorable in this region (Samee et al., 2008). It is observed that
electrostatic descriptors like E_1505 (41%) with positive coef-
ﬁcient suggest favorability of less electronegative group in
these regions for producing potent compounds. The com-
pounds (like 23–33, 35) with higher activity having less electro-
negative substitution (benzyl or pentaﬂurobenzyl) at the R4
position of b-carboline ring. The presence of steric descriptors
S_797 (17%), and S_1654 (25%) with positive coefﬁcient sug-
gests favorability of bulky groups in these regions for produc-
ing potent compounds. The compounds (like 2, 3, 4, 5, 6, 7)
having higher activity with bulky DNA targeting substitution
(-CONH (CH2)n NH2 or amino alkyl long side chain) at the
R3 position of b-carboline ring. Most of the compounds (like
11–17, 34–38) with higher activity having bulky substitution
(alkyl or aryl side chain) at the R2 position of b-carboline ring
strongly support the above comment. It is observed that steric
descriptor like S_927 (17%) with negative coefﬁcient is far
from the b-carboline structure indicating that bulky groups
are unfavorable on this site and the presence of less bulky
groups is favorable for the activity.
The correlation between experimental and predicted activ-
ity for both training and test set of compounds is shown in
Table 4 and represented graphically in Fig. 1 respectively.
These results authenticate the good prediction ability of the
generated 3D QSAR model. The model summary dialog
box, showed the relative positions of the local ﬁelds around
aligned molecules that were important for activity variation
in the model (Figs. 4 and 5).
4. Conclusions
The present work reveals how a set of antitumor activity of
various b-carboline may be treated statistically to ﬁnd out
the molecular characteristics which are essential for high activ-
ity. 3D-QSAR studies have been carried out on a series of b-carboline derivatives with antitumor activity. Additionally,
we wish that the current study provides better insight into
the designing of more potent b-carboline derivatives as antitu-
mor in the future before their synthesis.Acknowledgments
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